The Pink Pill: De-stigmatizing women's libido
You may know Viagra as the "blue pill" but what about Addyi, the "pink pill"?
Addyi was first approved in the U.S. in 2015 to treat hypoactive sexual desire disorder (HSDD) – the medical term for women experiencing low libidos. According to the National Institutes of Health, it is "the most commonly identified sexual problem among women." It was first identified in 1977 but getting drugs to market for women's sexual health faces unique challenges. Addyi is one of two approved drugs that help improve women's low libido, while 26 drugs have been approved for male sexual health by the U.S…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.